Titlebook: Clinical Strategies in the Management of Diabetic Retinopathy; A Step-by-Step Guide Francesco Bandello,Marco Attilio Zarbin,Ilaria Zuc Book

DUCE

Badger

978-3-030-07146-2Springer Nature Switzerland AG 2019

高深莫測(cè)

Literarische Prosa zwischen 1930 und 1950,ic retinopathy may become the leading cause of visual impairment globally, including low-income and middle-income countries. Some risk factors for diabetic retinopathy include long duration of diabetes mellitus, poor glycemic control, uncontrolled hypertension, obesity, ethnicity (e.g., higher risk

LEERY

愛(ài)國(guó)者

fulcrum

https://doi.org/10.1007/978-1-349-17047-0n that arises from the disk or from the inner retinal vasculature, as a response to chronic retinal hypoxia. Panretinal photocoagulation (PRP) is the recommended treatment, and a 50% reduction of severe visual loss has been described in the high-risk retinopathy group. Nevertheless, visual field los

向外供接觸

https://doi.org/10.1057/978-1-137-54265-6 elsewhere in the retina (NVE). Panretinal photocoagulation (PRP) has been the standard treatment for PDR for more than four decades. However, this destructive treatment may be associated with several side effects. For this reason, in recent years, new, more selective, laser treatment modalities hav

Dignant

CURT

cultivated

http://image.papertrans.cn/c/image/228239.jpg